Literature DB >> 15001272

Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

H Helen Liu1, Xiaochun Wang, Lei Dong, Qiuwen Wu, Zhongxing Liao, Craig W Stevens, Thomas M Guerrero, Ritsuko Komaki, James D Cox, Radhe Mohan.   

Abstract

PURPOSE: To investigate the possibility of using intensity-modulated radiotherapy (IMRT) to reduce the irradiated volumes of the normal lung and other critical structures in the treatment of non-small-cell lung cancer (NSCLC) and to investigate the effect of IMRT on the potential of spreading low doses to large volumes of normal tissues in such treatment. METHODS AND MATERIALS: A retrospective treatment planning study was performed to compare IMRT and conventional three-dimensional conformal radiation therapy (3D-CRT) for 10 NSCLC patients (Stage I-IIIB). In the IMRT plans, three to nine coplanar beams were designed to treat 95% of the planning target volume with 63 Gy and to minimize the volumes of the normal lung, esophagus, heart, and spinal cord irradiated above their tolerance doses. The two types of plans were compared with respect to the planning target volume coverage, dose-volume histograms, and other dosimetric indexes of the normal structures.
RESULTS: Comparing the nine-beam IMRT plan with the 3D-CRT plan, the percentage of lung volume that received >20 Gy and the mean lung dose were reduced for all cases, with a median reduction of 8% and 2 Gy, respectively. An additional reduction of the >5-Gy volume and >10-Gy volume for the lung and thoracic tissue was more difficult with IMRT, although still possible using fewer beams in IMRT. The integral dose to the entire thorax was equivalent and even reduced for 8 of 10 cases using IMRT.
CONCLUSION: It is possible to reduce the volumes of low doses (such as the >10-Gy volume and >20-Gy volume) for thoracic normal tissues using IMRT. The increased integral dose and low-dose volumes can be avoided for IMRT if such concerns are addressed carefully in the inverse planning process and with optimization of the IMRT beam configuration.

Entities:  

Mesh:

Year:  2004        PMID: 15001272     DOI: 10.1016/j.ijrobp.2003.09.085

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  50 in total

1.  A prospective phase II study of magnetic resonance imaging guided hematopoietical bone marrow-sparing intensity-modulated radiotherapy with concurrent chemotherapy for rectal cancer.

Authors:  Wang Jianyang; Tian Yuan; Tang Yuan; Wang Xin; Li Ning; Ren Hua; Fang Hui; Feng Yanru; Wang Shulian; Song Yongwen; Liu Yueping; Wang Weihu; Li Yexiong; Jin Jing
Journal:  Radiol Med       Date:  2015-11-27       Impact factor: 3.469

Review 2.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

3.  Esophagus and spinal cord motion relative to GTV motion in four-dimensional CTs of lung cancer patients.

Authors:  Elisabeth Weiss; Krishni Wijesooriya; Paul Keall
Journal:  Radiother Oncol       Date:  2008-02-21       Impact factor: 6.280

4.  Comparison of intensity-modulated radiotherapy planning based on manual and automatically generated contours using deformable image registration in four-dimensional computed tomography of lung cancer patients.

Authors:  Elisabeth Weiss; Krishni Wijesooriya; Viswanathan Ramakrishnan; Paul J Keall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-19       Impact factor: 7.038

Review 5.  The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer.

Authors:  Zhengfei Zhu; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2015-06

6.  Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.

Authors:  M Guckenberger; A Kavanagh; M Partridge
Journal:  Strahlenther Onkol       Date:  2012-08-31       Impact factor: 3.621

7.  Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.

Authors:  Marta Scorsetti; Piera Navarria; Fiorenza De Rose; AnnaMaria Ascolese; Elena Clerici; Ciro Franzese; Francesca Lobefalo; Giacomo Reggiori; Pietro Mancosu; Stefano Tomatis; Antonella Fogliata; Luca Cozzi
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-17       Impact factor: 4.553

8.  Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.

Authors:  Jingbo Wang; Zongmei Zhou; Jun Liang; Qinfu Feng; Zefen Xiao; Zhouguang Hui; Xiaozhen Wang; Jima Lv; Dongfu Chen; Hongxing Zhang; Zhe Ji; Jianzhong Cao; Lipin Liu; Wei Jiang; Yu Men; Cai Xu; Jiangrong Dai; Weibo Yin; Luhua Wang
Journal:  Oncologist       Date:  2016-09-14

9.  Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

Authors:  Sonal Sura; Vishal Gupta; Ellen Yorke; Andrew Jackson; Howard Amols; Kenneth E Rosenzweig
Journal:  Radiother Oncol       Date:  2008-03-17       Impact factor: 6.280

10.  Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc.

Authors:  Marta Scorsetti; Pierina Navarria; Pietro Mancosu; Filippo Alongi; Simona Castiglioni; Raffaele Cavina; Luca Cozzi; Antonella Fogliata; Sara Pentimalli; Angelo Tozzi; Armando Santoro
Journal:  Radiat Oncol       Date:  2010-10-15       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.